Angel Insights

Angel Insights | Your guide to angel investing

Business EN ↓ 114 episodes

For the sophisticated British investor and high-net-worth individual, "Angel Insights" is the definitive guide to mastering early-stage investing. We cut through the noise to deliver in-depth interviews with the UK's most influential angel investors, leading fund managers, and visionary founders. Host Tom Britton uncovers their playbooks: learn advanced investment strategies, rigorous due-diligence techniques, and the art of portfolio construction. Angel Insights is produced by www.syndicateroom.com

Be sure to visit the podcast's website and support the creator: www.syndicateroom.com

Author

Angel Insights

Category

Business

Podcast website

www.syndicateroom.com

Latest episode

Nov 19, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

"The barrier to demo is dead” - Inicio AI’s Rachel Curtis on why banks can’t build it themselves 19.11.2026

Anyone with an AI subscription can build a chatbot demo in an afternoon but try getting it into a regulated environment, or approved by the FCA, and you'll come up to a brick wall. On today's episode we're joined by Rachel Curtis , founder of Inicio AI . Rachel spent 30 years in financial services, starting on the counter of a building society, before building Budgi, a virtual agent th...

Less than 1% of pesticide hit the target: Viridys Bio's Stu Dixon on reading plant stress signals 12.11.2026

When an aphid bites a leaf, the plant sends out a chemical call for help. Farmers can't hear it, so when they spot a problem they spray the whole crop, and by some estimates less than 1% of that pesticide hits its target. On today's episode we're joined by Stu Dixon, co-founder and CEO of Viridys Bio, who is building battery-free biosensors that turn those invisible plant signals into...

"An absolutely bonkers product”: Joyvié’s Zoe Robson on the 17% nobody talks about 05.11.2026

Most continence products are built to absorb urine. Faeces can’t be absorbed, so it sits against the skin, and for people living with bowel incontinence that can mean sore skin, infections and a loss of dignity. On today’s episode we’re joined by Zoe Robson, founder and CEO of Acess EIS portfolio company Joyvié Health, who is redesigning continence care from first principles. Zoe tells us how her...

"We are selling our companies too early": angel Simon Thorpe on exits and the UK scale-up gap 28.10.2026

Britain is great at starting companies but less good at keeping them. Five years after his last visit, angel investor Simon Thorpe is back to explain why. On today's episode, we're joined by Simon Thorpe, founder of Delta2020, former chair of Cambridge Angels and a non-executive director on an Albion VCT board. Simon has backed more than 60 UK startups, with exits including SwiftKey to Mic...

Making retrofit an investable asset with GreenFlip's Amandeep Kalra 21.10.2026

England has millions of homes below EPC band C in need of updates. We have the technology to fix them, and pension funds are keen to pay for it, so why is retrofit still stuck at the pilot stage? On today’s episode, we’re joined by Amandeep Kalra , co-founder and CEO of GreenFlip , a Carbon13 portfolio company that prices the retrofit return on any UK home in about ten seconds, without a survey. A...

"Buyers are liars" - Inspir’em’s Emma Maslen on the 6 sales checks angels make before investing 14.10.2026

Most startups don’t fail because the product is bad. They fail because nobody can sell it. On today’s episode, we’re joined by Emma Maslen, CEO of sales consultancy inspir’em and an angel investor with Angel Academe. After a career selling for IBM, SAP and Concur, Emma now works with everyone from early-stage startups to Snowflake and Salesforce. She explains how she tests a startup’s ability to s...

"Your coffee cuts blood flow to your brain by 30%": Thomas Kirk on whether dementia drugs work 08.10.2026

Here's a fact we didn't expect: that coffee you're holding cuts blood flow to your brain by around 30%. Today's guest has built technology that can see it happening, and the bigger prize is using it to show whether the new wave of Alzheimer's drugs is working for each patient. On today's episode, we're joined by Thomas Kirk, co-founder and CEO of Quantified Imaging. Tho...

99% of AI investors will lose money -and that's expected. Oli Hammond, Fuel Ventures 27.07.2026

Could the first wave of AI turn out to be a capital destruction event? On today's episode we're joined by Oli Hammond, Partner at Fuel Ventures, where he leads seed rounds of £1–2 million into B2B companies — and, full disclosure, a SyndicateRoom alumnus who started his career with us before going on to bigger things. Oli believes AI will create enormous value — for a very small number of...

The Google Maps of Heat Loss with Lucy Lyons, Co-founder & CEO of Kestrix 18.06.2026

The UK is set to spend ~£15bn upgrading 5 million homes by 2030 — but much of the insulation we've already paid for is failing, and the way we survey buildings hasn't really changed in 30 years. Lucy Lyons is fixing that. Her company, Kestrix, flies thermal imaging drones over buildings to map exactly where heat is escaping — and has already covered around 12,000 homes. In this episode, Tom and Lu...

From Pig Farmer to Top 1% Angel Investor: Alister Esam's Framework for Backing Winners 28.05.2026

How does someone go from Pig Farmer, to Actuary, to successfully exited Entrepreneur, and now top 1% Angel Investor? I sat down with Alister Esam to find out and to unpack the hard-won investing framework behind his success and the portfolio companies he backs. Tune in as Alister explains why he ignores the hype, which metrics matter at the seed stage, and how he's now opening his deal flow to...

The £237 Billion Repayment Gap: Revolutionising Debt with Hannah Baynham (haboo money) 29.03.2026

While the last decade of FinTech made accessing credit as easy as a single swipe, the technology behind repaying that debt remained stuck in the dark ages of rigid direct debits and impersonal collections. With UK unsecured consumer debt hitting a staggering £237 billion—averaging £4,400 per adult—the "repayment gap" represents one of the largest untapped opportunities in financial servi...

Colin Van Ostern: Why Alumni Ventures is Betting on UK Venture Capital 24.02.2026

In this episode, SyndicateRoom Co-founder Tom Britton sits down with Colin Van Ostern , the incoming Head of UK and EMEA for Alumni Ventures , to discuss the fundamental shift toward a multi-polar venture capital landscape. While much of the media narrative has focused on a "funding winter," the ground-level reality tells a different story. As one of the world’s most active venture firms...

The 1% mission: why Europe’s climate tech future runs through industrial giants, not consumer apps 06.02.2026

“We are looking for one thing: people who want to start a business in climate, and want to start it now .” In this episode of Angel Insights, host Tom Britton sits down with Michael Langguth , Founding Partner of Carbon 13 , the venture builder for the climate emergency. While much of the climate conversation focuses on consumer habits, Michael and his team are focused on the "hard stuff&quot...

Profitability, Pivots, and Why AI Needs Trustworthy Data with Jessi Baker MBE 09.12.2025

Join Tom Britton and Jessi Baker, MBE (Founder & Chair of Provenance), as they break down the brutal choices founders must make to build a resilient, market-leading B2B SaaS company. In this episode, Jessi discusses: Strategic Flexibility: Why she made the critical decision to cut profitable consulting services to focus solely on scalable SaaS and the lessons learned from being an early blockc...

The Startup Building Edible Insulation to Tackle a 1.4 Gigaton CO2 Problem 04.11.2025

Heating and cooling drive 40% of all energy-related CO2 emissions, yet 60% of that energy is wasted by bad insulation. Is there a better way? We got the chance to speak with Theresa Hoffmann, founder of Nanoplume, a UK startup that has developed a revolutionary bio-aerogel 3x more insulating and 60% thinner than traditional materials. The technology is so non-toxic that she famously eats it during...

Temperate: The Tech Beaming Heat Into Space to Disrupt the Trillion-Dollar Cooling Market | Angel Insights 22.10.2025

Temperate: The startups building tech that beams heat into space and aims to disrupt the trillion-dollar cooling market Air conditioning consumes 10% of the world's electricity, a figure set to double by 2050. Is there a better way? I got the chance to speak with Charlie, founder of Temperate, a UK startup that has developed a revolutionary cooling technology up to 20 times more efficient than...

An angel’s prescription: Pam Garside’s guide to spotting winning health tech founders 15.09.2025

Join us for a fascinating conversation with Pam Garside, a leading angel investor in the health tech sector and the first female chair of Cambridge Angels. Pam shares her unique journey from managing NHS organisations to becoming a trusted advisor and investor, offering a rare glimpse into how a true healthcare insider evaluates early-stage startups. In this episode, Pam reveals her "prescrip...

Backing resilient founders from the CEO who turned Avon around during Covid 23.07.2025

Angela Cretu spent 25 years at Avon, rising from area manager to Global CEO, where she led one of the most remarkable corporate turnarounds in recent history. Taking over in January 2020 when the company was predicted to go bankrupt, she navigated COVID-19 as a new CEO and transformed one of the world's most recognised beauty brands. After stepping down in 2024, Angela made a fascinating caree...

The wandering professional's discovery: how Jodie O'Keeffe turned three careers into angel investing mastery 08.07.2025

In this episode, we explore Jodie O'Keeffe's fascinating journey from IT contractor in 1990s Australia to becoming one of Angel Academe's most insightful investors. Starting with a chance magazine discovery in a Melbourne supermarket, Jodie shares how her unconventional career path through technology, journalism, and philanthropy unexpectedly converged into angel investing expertise. W...

From late-night copy machine frustration to corporate revolution: how deployed tackles the billions spent on enterprise procurement 17.06.2025

Standing at a copy machine at HSBC late one night, reviewing 50 statements of work that needed urgent attention, Kayleigh Kuptz had her lightbulb moment. "Technology should do this," she thought, "this should not be done by me." Four years later, that frustration has become Deployed—a B2B SaaS platform that's saving enterprise clients millions while transforming how corpora...

From Empty Planes to Full Pints: How Days Brewing is Redefining Beer for the Health-Conscious Generation 10.06.2025

The last flight out of London carried just two passengers on that fateful March day in 2020. As Boris Johnson announced the UK's first lockdown, Mike Gammell and his co-founder Duncan were airborne, heading to Scotland with nothing but faith in their vision for alcohol-free beer. Four years later, Days Brewing has become the fastest-growing brand in the UK's no and low alcohol space, provi...

25 years of angel investing: hard-won lessons from Simon Blakey 30.05.2025

How a biochemist turned management consultant became one of the UK's most experienced angel investors — and what new angels can learn from his journey. When Simon Blakey made his first angel investment in 2000, the startup ecosystem looked radically different. There was no AngelList, no Seed Legals, and certainly no standardised term sheets. Finding deals meant subscribing to the "Venture...

SEIS or EIS? It shouldn’t be a question of one over the other.. 12.05.2025

On today's episode, we are joined by Aled Phillips, Co-Managing Director at Niche Private Clients, who helps us take an in-depth look at the Seed Enterprise Investment Scheme (SEIS) and Enterprise Investment Scheme (EIS) , their similarities, differences, and when they might be right for your investment strategy. It's a fascinating discussion that we hope you enjoy. Please do leave a comme...

How Deep Blue Biotech is reprogramming bacteria to produce chemicals and eat CO2 09.04.2025

In a world searching for sustainable alternatives to fossil fuel-derived products, Deep Blue Biotech – a graduate of climate-tech-focused fund Carbon13 ’s 2023  Venture Builder programme – is making waves with an innovative approach to chemical production. Using cyanobacteria – one of the most efficient photosynthetic organisms on the planet – they're developing technology that not only create...

Moth Drinks: How a single litre of Chai Masala Old Fashioned turned into a global premium ready-to-drink brand. 17.03.2025

In the latest episode of Angel Insights, we sat down with Rob Wallis, co-founder of Moth Drinks, a SyndicateRoom portfolio company revolutionizing the ready-to-drink (RTD) cocktail market. From humble beginnings in a home kitchen to expanding across the Atlantic, Moth has established itself as a premium brand in a rapidly growing category. Here's how they did it. For more information on the Ac...

Listen to the Angel Insights | Your guide to angel investing podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.